Companies: 10,795·Total market cap: $144.5T
Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc.

PLXAMEXHealthcare● Active
$1.96
$-0.03(-1.51%)
Market Cap$157920418
P/E Ratio
52W High$3.19
52W Low$1.32
Overview

Protalix BioTherapeutics, Inc.(PLX)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PLX · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$30.27M$34.83M$44.56M$22.18M$38.98M
Net Receivables$8.84M$2.91M$5.27M$4.59M$3.44M
Inventory$25.73M$21.24M$19.05M$16.80M$17.95M
Total Current Assets$66.67M$60.08M$69.93M$44.88M$61.67M
PP&E Net$12.58M$10.02M$10.88M$9.64M$9.92M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.00M$0.00M$0.00M$0.00M$0.00M
Total Assets$82.35M$73.42M$84.43M$55.79M$73.67M
Liabilities
Short-Term Debt$0.00M$0.00M$21.66M$0.00M$0.00M
Accounts Payable$5.26M$4.53M$4.32M$5.86M$6.99M
Total Current Liabilities$26.52M$25.62M$45.53M$32.43M$33.18M
Long-Term Debt$0.00M$0.00M$0.00M$28.19M$27.89M
Total Liabilities$34.12M$30.21M$50.87M$66.43M$79.70M
Stockholders Equity
Retained Earnings($385.00M)($378.39M)($381.55M)($389.86M)($374.93M)
Total Stockholders Equity$48.23M$43.21M$33.57M($10.64M)($6.04M)
Total Liab & Equity(computed)$82.35M$73.42M$84.43M$55.79M$73.67M
Debt Summary
Total Debt$8.32M$5.53M$27.69M$33.47M$33.47M
Net Debt($6.36M)($14.23M)$4.06M$16.36M($5.51M)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Protalix BioTherapeutics, Inc.

关于Protalix BioTherapeutics, Inc.(PLX)资产负债表

Protalix BioTherapeutics, Inc.总资产$0.08B,现金及短期投资$0.03B,总负债$0.03B,总债务$0.01B,股东权益$0.05B。

常见问题

PLX · 4 问

Protalix BioTherapeutics, Inc.总债务$0.01B,净债务($0.01B)。

PLX total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10